Financial News
Headline News about Arrowhead Pharma
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Arrowhead Pharma
November 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/10/31/jnj.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Analyst Expectations for Arrowhead Pharma's Future
September 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
September 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/08/jim_cramer_shutterstock2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Ratings for Arrowhead Pharma
August 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Arrowhead Pharma's Future
July 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Arrowhead Pharma
June 30, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/10/Stock-vervetherapeutics-01-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2023/06/A1-060523-Bigpharma-chrisgash.jpg)
![](/next-assets/images/schema-image-default.png)
Where Arrowhead Pharma Stands With Analysts
May 24, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2019/11/Stock-Drugs-74-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/23/aapharma_11.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Arrowhead Pharma
May 03, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/727985/investor-looking-for-stocks-getty.jpg)
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Arrowhead Pharma
April 12, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Arrowhead Pharma
March 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/25/ge_healthcare_technologies_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/729482/vir-biotechnology.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/25/arwr.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/04/25/xerox_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 25, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/12/arwr.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/727011/blood-sample.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/12/panbela_therapeutics_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/15/arwr_logo_light__622e712862838745f5772844be5cb182.png?width=1200&height=800&fit=crop)
JNJ Terminates NASH Program Pact With Arrowhead Pharmaceuticals
February 15, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.